跳至主要内容
临床试验/ITMCTR2000003300
ITMCTR2000003300尚未招募4 期

Clinical study for the effect of Zhenyuan capsule on Cardiopulmonary function in patients with stable Coronary Heart Disease

Xiyuan Hospital of Chinese Academy of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • 1. Results of coronary angiography or spiral CT: coronary stenosis >= 50%, or clear history of myocardial infarction, or stable condition more than one month after ACS treatment (PCI, CABG);
  • 2. Patients with LVEF >= 40%;
  • 3. Patients with angina I-II (CCS grade);
  • 4. Patients with Qi deficiency and blood stasis syndrome;
  • 5. Patients aged 18 to 75 years;
  • 6. The patients who are in line with the risk stratification of coronary heart disease and have low risk of cardiac rehabilitation can be rehabilitated by exercise cardio pulmonary;
  • 7. Patients willing to sign informed consent.

排除标准

  • 1. Patients with acute myocardial infarction, unstable angina, or within one month after PCI or CABG;
  • 2. Patients with absolute and relative contraindications for cardiopulmonary exercise test;
  • 3. Patients who took Zhenyuan capsule in the last month or who participated in other clinical trials in the last month;
  • 4. In the patients with renal insufficiency, serum creatinine was more than 2.5mg/dl in men and more than 2.0mg/dl in women;
  • 5. Patients with obvious liver disease or ALT and AST were 3 times higher than the upper limit of normal;
  • 6. New York Heart Function (NYHA) grade IV, or patients with recurrent malignant arrhythmias;
  • 7. Patients with chronic obstructive pulmonary disease or even respiratory failure, or patients with pulmonary infection;
  • 8. Patients with diabetes mellitus whose blood glucose >=13.7mmol/l or HbA1c was >= 9.5%;
  • 9. Pregnant or preparing pregnant women and lactating women;
  • 10. Patients with acute cerebrovascular disease; malignant tumor or patients with life expectancy less than 1 year; patients with severe hematopoietic system disease; patients with severe mental disease;
  • 11. Patients who are allergic to known components of the study drug.

研究者

发起方
Xiyuan Hospital of Chinese Academy of Traditional Chinese Medicine

相似试验